CORALVILLE, Iowa (Business Wire) -- Vivakor, Inc. (OTCBB: VIVK), a biomedical/biotechnology innovation company, announced today that its Executive Chairman Matt Nicosia will conduct an exclusive new audio-taped webcast interview so that VIVK shareholders and the investment community can learn more about the Company's recently developments and growth plans. Unrestricted access to the webcast will be available beginning on Tuesday, November 10 at www.TheGreenBaron.com. Investors who wish to receive The Green Baron Report for free can join at http://www.thegreenbaron.com/Join.htm.
The Green Baron Report also initiated coverage of Vivakor, Inc. as a new “Stock Pick” through its report released after the close of trading on Monday, November 2, 2009 and is available at TheGreenBaron.com website. The report describes Vivakor's four divisions that focus on prevention and detection to extend and improve life, and how its diversified product mix and chance for healthy revenues in the near term make this a rare find in the biotech industry.
About Vivakor, Inc.
Vivakor™ is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. More information can be found about Vivakor at www.vivakor.com.
About The Green Baron Report
The Green Baron Report is a subsidiary of Evergreen Marketing. The Green Baron Report is an internet stock market newsletter that focuses on low priced stocks that appear to have significant upside potential. For more information about Evergreen Marketing, Inc. and their subsidiary The Green Baron Investors Society visit them on the web at http://www.EvergreenMarketingInc.com and http://www.TheGreenBaron.com or http://www.StrictlyStocks.com. Our disclaimer can be viewed at http://www.thegreenbaron.com/Disclaimer.htm.
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's research and development and strategic activities. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The success of such activities depends on a number of factors, including the risks that Vivakor may not generate sufficient cash from operations and from external financing to continue as a going concern or to complete its products under development; that Vivakor may not be successful in securing any licensing, partnering or M&A arrangements; that patents may not issue from its patent applications; that competitors may challenge or design around Vivakor's patents or develop competing technologies. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
© Business Wire
